Response to Selective RET Inhibition With LOXO-292 in a Patient With RET Fusion-Positive Lung Cancer With Leptomeningeal Metastases

Detalles Bibliográficos
Autores principales: Guo, Robin, Schreyer, Mark, Chang, Jason C., Rothenberg, S. Michael, Henry, Dahlia, Cotzia, Paolo, Kris, Mark G., Rekhtman, Natasha, Young, Robert J., Hyman, David M., Drilon, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724540/
https://www.ncbi.nlm.nih.gov/pubmed/31485557
http://dx.doi.org/10.1200/PO.19.00021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724540/
https://www.ncbi.nlm.nih.gov/pubmed/31485557
http://dx.doi.org/10.1200/PO.19.00021

Ejemplares similares